.Vaxcyte introduced what professionals referred to as "sensational" period 1/2 information for its o...
.Recursion has stumbled via an early test of its tech-enabled technique to drug discovery, disclosin...
.Phone it a case of really good chemical make up: Acepodia, a biotech based on Nobel Prize-winning s...
.Practice Preciseness Medicines has scored another midphase succeed in epilepsy this year, with its ...
.After leaving a clinical grip several years back, Dyne Therapeutics has disclosed new stage 1/2 rec...
.Arrowhead Pharmaceuticals has revealed its give in advance of a prospective showdown with Ionis, re...
.Pfizer and also Valneva might possess regarding pair of even more years to stand by prior to they p...
.Let's dive into a discussion with Ayla Ellison, Ferocious Biotech Managing Editor and also Michelle...
.Bayer put on hold the phase 3 trial for its own aspect XIa inhibitor asundexian behind time in 2015...
.Sanofi is still bented on taking its own a number of sclerosis (MS) med tolebrutinib to the FDA, ex...